WHITNEY URNER: Open Payments
NPI 1902242530 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 16 payments from 9 companies in 2025. Trend: 2023 $358 · 2024 $385 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $199 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| ABBVIE INC. | 2 | $40 |
| Organon LLC | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Incyte Corporation | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
Products named: DUPIXENT, Rhapsido, SKYRIZI, TREMFYA, TALTZ, OPZELURA, Zoryve, YCANTH.
Industry payments across CA — which companies pay providers there.
